Acadia Pharmaceuticals | ACAD - Capitalização De Mercado





Capitalização De Mercado Alterar Data
Acadia Pharmaceuticals USD 3.8B 724M 2026-03
ALKERMES USD 5.88B 1.26B 2026-03
Alnylam Pharmaceuticals USD 44.15B 8.39B 2026-03
Biogen USD 26.9B 1.09B 2026-03
BioMarin Pharmaceutical USD 10.86B 553M 2026-03
Bristol-Myers Squibb USD 123.83B 14.02B 2026-03
Cara Therapeutics USD 366M 338M 2025-09
Corcept Therapeutics USD 4.32B 654M 2026-03
Cytokinetics USD 8.19B 420M 2026-03
Eisai JPY 1.42T 110.62B 2026-03
Eli Lilly USD 869.02B 146.97B 2026-03
Incyte USD 18.73B 660M 2026-03
J&J USD 602.98B 8.38B 2026-07
Moderna USD 20.15B 8.53B 2026-03
Neurocrine Biosciences USD 13.25B 890M 2026-03
Pfizer USD 153.81B 12.24B 2026-03
Prothena USD 526M 10M 2026-07
PTC Therapeutics USD 5.64B 460M 2026-03
Sarepta Therapeutics USD 2.28B 30M 2026-03
Ultragenyx Pharmaceutical USD 2.06B 159M 2026-03
Vanda Pharmaceuticals USD 279M 6M 2024-12
Vertex Pharmaceuticals USD 113.58B 1.44B 2026-03